Lipoarabinomannan in urine during tuberculosis treatment : association with host and pathogen factors and mycobacteriuria
Date
2012-02
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
Abstract
ABSTRACT: Background: Detection of lipoarabinomannan (LAM), a Mycobacterium tuberculosis (Mtb) cell wall antigen, is a potentially attractive diagnostic. However, the LAM-ELISA assay has demonstrated variable sensitivity in diagnosing TB in diverse clinical populations. We therefore explored pathogen and host factors potentially impacting LAM detection. Methods: LAM-ELISA assay testing, sputum smear and culture status, HIV status, CD4 cell count, proteinuria and TB outcomes were prospectively determined in adults diagnosed with TB and commencing TB treatment at a South African township TB clinic. Sputum TB isolates were characterised by IS61110-based restriction fragment length polymorphism (RFLP) and urines were tested for mycobacteriuria by Xpert® MTB/RIF assay. Results: 32/199 (16.1%) of patients tested LAM-ELISA positive. Median optical density and proportion testing LAM positive remained unchanged during 2 weeks of treatment and then declined over 24 weeks. LAM was associated with positive sputum smear and culture status, HIV infection and low CD4 cell counts but not proteinuria, RFLP strain or TB treatment outcome. The sensitivity of LAM for TB in HIV-infected patients with CD4 counts of ≥ 200, 100-199, 50-99, and < 50 cells/μl, was 15.2%, 32%, 42.9%, and 69.2% respectively. Mycobacteriuria was found in 15/ 32 (46.9%) of LAM positive patients and in none of the LAM negative controls. Conclusions: Urinary LAM was related to host immune factors, was unrelated to Mtb strain and declined steadily after an initial 2 weeks of TB treatment. The strong association of urine LAM with mycobacteriuria is a new finding, indicating frequent TB involvement of the renal tract in advanced HIV infection.
Description
The original publication is available at http://www.biomedcentral.com/1471-2334/12/47
Bibliography
Bibliography
Keywords
Lipoarabinomannan (LAM), Mycobacterium tuberculosis (Mtb), Tuberculosis -- Diagnosis, Pathogens impacting LAM, HIV-positve patients -- Tuberculosis -- Research, Renibacterium salmoninarum -- Research
Citation
Wood, R. et al 2012. Lipoarabinomannan in urine during tuberculosis treatment : association with host and pathogen factors and mycobacteriuria. BMC Infectious Diseases, 12(1):47